FR2307539B1 - - Google Patents

Info

Publication number
FR2307539B1
FR2307539B1 FR7611480A FR7611480A FR2307539B1 FR 2307539 B1 FR2307539 B1 FR 2307539B1 FR 7611480 A FR7611480 A FR 7611480A FR 7611480 A FR7611480 A FR 7611480A FR 2307539 B1 FR2307539 B1 FR 2307539B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7611480A
Other versions
FR2307539A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of FR2307539A1 publication Critical patent/FR2307539A1/fr
Application granted granted Critical
Publication of FR2307539B1 publication Critical patent/FR2307539B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C07J19/005—Glycosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7611480A 1975-04-18 1976-04-16 Nouveaux glucosides de la serie des cardenolides, procede pour leur preparation et medicaments cardio-actifs les contenant Granted FR2307539A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2517293A DE2517293C2 (de) 1975-04-18 1975-04-18 Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung

Publications (2)

Publication Number Publication Date
FR2307539A1 FR2307539A1 (fr) 1976-11-12
FR2307539B1 true FR2307539B1 (fr) 1979-06-29

Family

ID=5944416

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7611480A Granted FR2307539A1 (fr) 1975-04-18 1976-04-16 Nouveaux glucosides de la serie des cardenolides, procede pour leur preparation et medicaments cardio-actifs les contenant

Country Status (12)

Country Link
US (1) US4001402A (fr)
JP (1) JPS51128958A (fr)
AT (1) AT347046B (fr)
BE (1) BE840248A (fr)
CH (1) CH624127A5 (fr)
DE (1) DE2517293C2 (fr)
DK (1) DK138125C (fr)
FR (1) FR2307539A1 (fr)
GB (1) GB1487720A (fr)
IE (1) IE43088B1 (fr)
LU (1) LU74789A1 (fr)
NL (1) NL7604070A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2948835A1 (de) * 1979-12-05 1981-06-11 Basf Ag, 6700 Ludwigshafen Neue c-3-verzweigte cardenolid-glykoside, ihre herstellung und verwendung
DE4221635C1 (de) * 1992-07-01 1994-05-05 Sigma Tau Ind Farmaceuti 3beta-Digitoxigenin- und 3beta-Dihydrodigitoxigenin-Derivate
DE4221538C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti 14-Desoxy-14alpha-cardenolid-3beta-thioderivate
US6380167B1 (en) 1999-02-12 2002-04-30 Primecyte, Inc. Methods for anti-tumor therapy
US7361478B2 (en) * 2001-11-20 2008-04-22 Allergan, Inc. High-throughput screen for identifying selective persistent sodium channels channel blockers
GB0713463D0 (en) 2007-07-11 2007-08-22 Btg Int Ltd Modulators of hypoxia inducible factor-1 and related uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1568015A1 (de) * 1966-06-18 1970-02-12 Asta Werke Ag Chem Fab Neue Acylderivate des Proscillaridin A und Verfahren zu ihrer Herstellung
US3963697A (en) * 1974-08-29 1976-06-15 Curtis Nuclear Corporation Labelled cardiotonic glycosides for use in radioimmunoassay

Also Published As

Publication number Publication date
GB1487720A (en) 1977-10-05
ATA273776A (de) 1978-04-15
FR2307539A1 (fr) 1976-11-12
DE2517293A1 (de) 1976-10-28
NL7604070A (nl) 1976-10-20
LU74789A1 (fr) 1977-01-12
AT347046B (de) 1978-12-11
BE840248A (fr) 1976-09-30
DK138125B (da) 1978-07-17
JPS51128958A (en) 1976-11-10
DK138125C (da) 1978-12-18
IE43088B1 (en) 1980-12-17
DE2517293C2 (de) 1984-02-16
IE43088L (en) 1976-10-18
CH624127A5 (fr) 1981-07-15
DK127176A (da) 1976-10-19
JPS618078B2 (fr) 1986-03-11
US4001402A (en) 1977-01-04

Similar Documents

Publication Publication Date Title
FR2307539B1 (fr)
JPS555399B2 (fr)
FR2330406B1 (fr)
JPS5728613B2 (fr)
JPS5761698B2 (fr)
JPS51134832U (fr)
JPS51155983U (fr)
JPS5442576Y2 (fr)
JPS573587Y2 (fr)
JPS54257B2 (fr)
JPS51107764A (fr)
JPS5290304U (fr)
JPS51106765U (fr)
JPS5196407U (fr)
JPS5230592U (fr)
JPS5230913U (fr)
CH598321A5 (fr)
CH600413B5 (fr)
LU76335A1 (fr)
CH600627A5 (fr)
CH600994A5 (fr)
CH606664A5 (fr)
CH601775A5 (fr)
CH601935A5 (fr)
CH602036A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse